Skip to content 
Search

Latest Stories

Demand still strong for India-made AstraZeneca vaccine: Gavi

Demand still strong for India-made AstraZeneca vaccine: Gavi

GLOBAL vaccine-sharing network Covax is still seeing strong demand for India-made doses of the AstraZeneca Covid-19 shot, its co-lead Gavi said, following comments from producer Serum Institute of India (SII) that uptake had slowed sharply.

The SII, the world's biggest vaccine maker, told India's CNBC-TV18 this week it would temporarily halve the vaccine's production as it had no fresh orders from the Indian government and Covax was taking fewer doses than the company could offer.


SII CEO Adar Poonawalla, whose company brands the shot Covishield, said Covax was placing orders but "that's very slow and the uptake will pick up in the next quarter". Covishield production is currently at 250 million doses a month.

Gavi said Covax had allocated 40 million Covishield doses to countries after New Delhi last month let the SII resume such supplies for the first time since April, and that it had the option to buy vaccines keeping a "flexible approach as the pandemic and countries' needs continue to evolve".

"We are still experiencing robust country demand for SII-Covishield," a Gavi spokesperson said in an email.

"Covishield will continue to play an important role within Covax’s diverse portfolio of vaccines ... to achieve higher coverage rates in lower-income countries."

Asked about the speed of vaccine orders and uptake, Gavi said the process takes time as doses need to be allocated to beneficiaries, plans put in place to administer them, approvals secured and shipment delivered.

"Covax's goal is to protect populations as quickly as possible but every care must be taken to ensure recipient countries are able to deploy the doses we send them," Gavi said.

"And this is why it is so important that all manufacturers provide as much transparency as possible as to when and in what quantity volumes will be supplied."

The SII has a deal to supply up to 550 million Covishield doses to Covax but has sent only about 37 million so far.

(Reuters)

More For You

Bangladesh seeks US deal to shield garment industry from tariffs

Workers are engaged at their sewing stations in a garment factory in Savar, on the outskirts of Dhaka, on April 9, 2025. (Photo by MUNIR UZ ZAMAN/AFP via Getty Images)

Bangladesh seeks US deal to shield garment industry from tariffs

BANGLADESH, the world's second-biggest garment manufacturer, aims to strike a trade deal with the US before Donald Trump's punishing tariffs kick in next week, said the country's top commerce official.

Dhaka is proposing to buy Boeing planes and boost imports of US wheat, cotton and oil in a bid to reduce the trade deficit, which Trump used as the reason for imposing painful levies in his "Liberation Day" announcement.

Keep ReadingShow less
UK business district
The Canary Wharf business district including global financial institutions in London.
Getty Images

Bond yields ease following Starmer’s support for Reeves

THE COST of UK government borrowing fell on Thursday, partially reversing the rise seen after Chancellor Rachel Reeves became emotional during Prime Minister’s Questions.

The yield on 10-year government bonds dropped to 4.55 per cent, down from 4.61 per cent the previous day. The pound also recovered slightly to $1.3668 (around £1.00), though it did not regain all its earlier losses.

Keep ReadingShow less
modi-trump-getty
Modi shakes hands with Trump before a meeting at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)
Getty Images

Indian exporters watch closely as Trump says trade deal with India likely

THE US could reach a trade deal with India that would help American companies compete more easily in the Indian market and reduce tariff rates, President Donald Trump said on Tuesday. However, he cast doubt on a similar deal with Japan.

Speaking to reporters on Air Force One, Trump said he believed India was ready to lower trade barriers, potentially paving the way for an agreement that would avoid the 26 per cent tariff rate he had announced on April 2 and paused until July 9.

Keep ReadingShow less
Kolhapuri sandal sales surge in India post Prada controversy

Customers shop for 'Kolhapuri' sandals, an Indian ethnic footwear, at a store in New Delhi, India, June 27, 2025. REUTERS/Adnan Abidi

Kolhapuri sandal sales surge in India post Prada controversy

INDIAN footwear sellers and artisans are tapping into nationalist pride stoked by the Prada 'sandal scandal' in a bid to boost sales of ethnic slippers with history dating back to the 12th century, raising hopes of reviving a struggling craft.

Sales are surging over the past week for the 'Kolhapuri' sandals that have garnered global attention after Prada sparked a controversy by showcasing similar designs in Milan, without initially crediting the footwear's origins.

Keep ReadingShow less
UK business district
The Canary Wharf business district including global financial institutions in London.
Getty Images

Economy grew 0.7 per cent in Q1 2025, fastest in a year

THE UK economy expanded at its fastest pace in a year during the first quarter of 2025, driven by a rise in home purchases ahead of a tax deadline and higher manufacturing output before the introduction of new US import tariffs.

Gross domestic product rose by 0.7 per cent in the January-to-March period, the Office for National Statistics (ONS) said, confirming its earlier estimate. This was the strongest quarterly growth since the first quarter of 2024.

Keep ReadingShow less